Acute Delirium, Delusion, and Depression During IFN-&bgr;-1a Therapy for Multiple Sclerosis: A Case Report
作者:
J. Goëb,
A. Cailleau,
P. Lainé,
F. Etcharry-Bouyx,
D. Maugin,
Ph. Duverger,
B. Gohier,
K. Rannou-Dubas,
F. Dubas,
J. Garré,
期刊:
Clinical Neuropharmacology
(OVID Available online 2003)
卷期:
Volume 26,
issue 1
页码: 5-7
ISSN:0362-5664
年代: 2003
出版商: OVID
关键词: Interferon-&bgr;-1a;Multiple sclerosis;Delirium;Delusion;Depression;Side effects
数据来源: OVID
摘要:
Adverse effects of interferon (IFN) treatment are common, and efforts to minimize these reactions are of considerable importance. IFN-&bgr;-1a is an established therapy for patients with relapsing–remitting multiple sclerosis (MS). Its psychiatric side effects are debated and not yet fully established. The authors report here the case of a patient on IFN-&bgr;-1a therapy for MS who developed acute delirium, delusion, and depression that ceased with treatment discontinuation. Although he had a history of recurrent major depressive disorder, his prior psychiatric illness had followed a course that was clinically independent of other signs of MS. This observation points out psychiatric vulnerability of patients taking IFN-&bgr;-1a therapy for MS and suggests that IFN-&bgr;-1a may induce or exacerbate preexisting psychotic symptoms.
点击下载:
PDF
(149KB)
返 回